Showing results (2151-2160 of 2,402) with videos related to
Sort By:
Pageof 241
Journal of the European Academy of Dermatology and Venereology : JEADV|September 7, 2020
A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacyA S Paller, E C Siegfried, E L Simpson, et al.JCO Clinical Cancer Informatics|June 17, 2021
Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor GradeAlessandra Pulvirenti, Rikiya Yamashita, Jayasree Chakraborty, et al.Dermatology and Therapy|May 3, 2024
Lebrikizumab Provides Rapid Clinical Responses Across All Eczema Area and Severity Index Body Regions and Clinical Signs in Adolescents and Adults with Moderate-to-Severe Atopic DermatitisEric L Simpson, Marjolein de Bruin-Weller, H Chih-Ho Hong, et al.American Journal of Perinatology|November 22, 2021
Obstetric Inpatient and Ultrasound Clinical Personnel Absences during the COVID-19 Pandemic in New York CityJessica Spiegelman, Clara Bertozzi-Villa, Mary E D'Alton, et al.Obstetrics and Gynecology|March 2, 2005
Late first-trimester placental disruption and subsequent gestational hypertension/preeclampsiaRichard K Silver, R Douglas Wilson, John Philip, et al.Frontiers in Physiology|February 11, 2020
Global REACH: Assessment of Brady-Arrhythmias in Andeans and Lowlanders During Apnea at 4330 mStephen A Busch, Sean van Diepen, Andrew R Steele, et al.Environmental Research|August 31, 2020
Decay of SARS-CoV-2 and surrogate murine hepatitis virus RNA in untreated wastewater to inform application in wastewater-based epidemiologyWarish Ahmed, Paul M Bertsch, Kyle Bibby, et al.Journal of the American Academy of Dermatology|February 8, 2018
Baricitinib in adult patients with moderate-to-severe atopic dermatitis: A phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose studyEmma Guttman-Yassky, Jonathan I Silverberg, Osamu Nemoto, et al.Immunological Reviews|June 29, 2017
Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthmaPhilip M Hansbro, Richard Y Kim, Malcolm R Starkey, et al.Journal of the American Academy of Dermatology|January 31, 2024
Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trialEric L Simpson, Jonathan I Silverberg, Margitta Worm, et al.Pageof 241